OpGen
OpGen is a precision medicine company harnessing the power of molecular diagnostics to help combat infectious diseases. They develop highly multiplexed syndromic molecular panels to address antimicrobial resistance (AMR), improve antibiotic stewardship, and decrease the spread of multidrug-resistant microorganisms. Their mission is to optimize the treatment of life-threatening, drug-resistant infections and transform patient care through advanced molecular microbiology.
Industries
Nr. of Employees
medium (51-250)
Patents
Systems, apparatus, and methods for generating and analyzing resistome profiles
US-10475526-B2
View Details
Systems, apparatus, and methods for generating and analyzing resistome profiles
US-10475526-B2
View DetailsProducts
Multiplex lower respiratory tract infection molecular panel
Syndromic molecular assay for rapid detection of common lower respiratory bacterial pathogens and multiple resistance markers directly from respiratory specimens; designed to shorten time-to-result compared to culture.
Hospital-acquired pneumonia / secondary bacterial pneumonia molecular panel
Molecular panel application intended for detection of bacterial pathogens implicated in hospital-acquired or secondary bacterial pneumonia, including use in COVID-19 patient cohorts.
Unyvero
Comprehensive testing panel and multiplex PCR system that accurately detects clinically relevant pathogens and antibiotic resistance markers associated with pneumonia directly from native specimens.
Gram-Negative QuickFISH BC
A multicolor, qualitative nucleic acid hybridization assay intended for the rapid identification of Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae on smears from positive blood cultures containing Gram-negative bacilli.
Staphylococcus QuickFISH BC
A multicolor, qualitative nucleic acid hybridization assay intended for the rapid identification of Staphylococcus aureus and/or coagulase-negative staphylococci from positive blood cultures.
GNR Traffic Light PNA FISH Culture Identification Kit
A multicolor, qualitative nucleic acid hybridization assay intended for the identification of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa on smears from positive blood cultures containing Gram-negative rods.
Multiplex lower respiratory tract infection molecular panel
Syndromic molecular assay for rapid detection of common lower respiratory bacterial pathogens and multiple resistance markers directly from respiratory specimens; designed to shorten time-to-result compared to culture.
Hospital-acquired pneumonia / secondary bacterial pneumonia molecular panel
Molecular panel application intended for detection of bacterial pathogens implicated in hospital-acquired or secondary bacterial pneumonia, including use in COVID-19 patient cohorts.
Unyvero
Comprehensive testing panel and multiplex PCR system that accurately detects clinically relevant pathogens and antibiotic resistance markers associated with pneumonia directly from native specimens.
Gram-Negative QuickFISH BC
A multicolor, qualitative nucleic acid hybridization assay intended for the rapid identification of Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae on smears from positive blood cultures containing Gram-negative bacilli.
Staphylococcus QuickFISH BC
A multicolor, qualitative nucleic acid hybridization assay intended for the rapid identification of Staphylococcus aureus and/or coagulase-negative staphylococci from positive blood cultures.
GNR Traffic Light PNA FISH Culture Identification Kit
A multicolor, qualitative nucleic acid hybridization assay intended for the identification of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa on smears from positive blood cultures containing Gram-negative rods.
Services
Design and conduct of analytical and clinical studies, including multicenter trials and retrospective reviews, to evaluate diagnostic panels and their clinical impact.
Supply of control materials and datasheets to support laboratory verification and ongoing quality control of molecular respiratory panels.
Channels for customer inquiries and technical assistance related to diagnostic products and services.
Design and conduct of analytical and clinical studies, including multicenter trials and retrospective reviews, to evaluate diagnostic panels and their clinical impact.
Supply of control materials and datasheets to support laboratory verification and ongoing quality control of molecular respiratory panels.
Channels for customer inquiries and technical assistance related to diagnostic products and services.
Expertise Areas
- Infectious disease molecular diagnostics
- Lower respiratory tract infection testing
- Antimicrobial resistance detection
- Clinical performance validation and multicenter trials
Key Technologies
- Multiplex PCR / multiplex nucleic acid amplification
- Syndromic molecular panels
- Resistance gene detection assays
- Culture-independent pathogen detection